Previous Article | Next Article 
Infection and Immunity, August 2004, p. 4801-4809, Vol. 72, No. 8
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.8.4801-4809.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Murine Model of Pulmonary Anthrax: Kinetics of Dissemination, Histopathology, and Mouse Strain Susceptibility
C. Rick Lyons,1* Julie Lovchik,1 Julie Hutt,2 Mary F. Lipscomb,1 Eugenia Wang,3 Sara Heninger,1 Lucy Berliba,1 and Kristin Garrison1
Departments of Internal Medicine and Pathology, University of New Mexico Health Sciences Center,1
Lovelace Respiratory Research Institute, Albuquerque, New Mexico,2
Department of Biochemistry and Molecular Biology, University of Louisville, Louisville, Kentucky3
Received 5 March 2004/
Returned for modification 30 March 2004/
Accepted 7 May 2004
Bioweapons are most often designed for delivery to the lung, although this route is not the usual portal of entry for many of the pathogens in the natural environment. Vaccines and therapeutics that are efficacious for natural routes of infection may not be effective against the pulmonary route. Pulmonary models are needed to investigate the importance of specific bacterial genes in virulence, to identify components of the host immune system that are important in providing innate and acquired protection, and for testing diagnostic and therapeutic strategies. This report describes the characteristics of host and Bacillus anthracis interactions in a murine pulmonary-infection model. The infective dose varied depending on the route and method of inoculation. The germination process in the lung began within 1 h of inoculation into the lung, although growth within the lung was limited. B. anthracis was found in the lung-associated lymph nodes
5 h after infection. Minimal pneumonitis was associated with the lung infection, but significant systemic pathology was noted after dissemination. Infected mice typically succumbed to infection
3 to 4 days after inoculation. The 50% lethal doses differed among inbred strains of mice, but within a given mouse strain, neither the age nor the sex of the mice influenced susceptibility to B. anthracis.
* Corresponding author. Mailing address: Infectious Disease and Inflammation Program, Department of Internal Medicine, University of New Mexico Health Science Center 1, University of New Mexico, Ms.c.10 5550, Albuquerque, NM 87131. Phone: (505) 272-4450. Fax: (505) 272-9912. E-mail:
clyons{at}salud.unm.edu.
Editor: J. D. Clements
Infection and Immunity, August 2004, p. 4801-4809, Vol. 72, No. 8
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.8.4801-4809.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Panchal, R. G., Ulrich, R. L., Bradfute, S. B., Lane, D., Ruthel, G., Kenny, T. A., Iversen, P. L., Anderson, A. O., Gussio, R., Raschke, W. C., Bavari, S.
(2009). Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis. J. Biol. Chem.
284: 12874-12885
[Abstract]
[Full Text]
-
Samant, S., Hsu, F.-F., Neyfakh, A. A., Lee, H.
(2009). The Bacillus anthracis Protein MprF Is Required for Synthesis of Lysylphosphatidylglycerols and for Resistance to Cationic Antimicrobial Peptides. J. Bacteriol.
191: 1311-1319
[Abstract]
[Full Text]
-
Chand, H. S., Drysdale, M., Lovchik, J., Koehler, T. M., Lipscomb, M. F., Lyons, C. R.
(2009). Discriminating Virulence Mechanisms among Bacillus anthracis Strains by Using a Murine Subcutaneous Infection Model. Infect. Immun.
77: 429-435
[Abstract]
[Full Text]
-
Lisanby, M. W., Swiecki, M. K., Dizon, B. L. P., Pflughoeft, K. J., Koehler, T. M., Kearney, J. F.
(2008). Cathelicidin Administration Protects Mice from Bacillus anthracis Spore Challenge. J. Immunol.
181: 4989-5000
[Abstract]
[Full Text]
-
Russell, B. H., Liu, Q., Jenkins, S. A., Tuvim, M. J., Dickey, B. F., Xu, Y.
(2008). In Vivo Demonstration and Quantification of Intracellular Bacillus anthracis in Lung Epithelial Cells. Infect. Immun.
76: 3975-3983
[Abstract]
[Full Text]
-
Sanz, P., Teel, L. D., Alem, F., Carvalho, H. M., Darnell, S. C., O'Brien, A. D.
(2008). Detection of Bacillus anthracis Spore Germination In Vivo by Bioluminescence Imaging. Infect. Immun.
76: 1036-1047
[Abstract]
[Full Text]
-
McKevitt, M. T., Bryant, K. M., Shakir, S. M., Larabee, J. L., Blanke, S. R., Lovchik, J., Lyons, C. R., Ballard, J. D.
(2007). Effects of Endogenous D-Alanine Synthesis and Autoinhibition of Bacillus anthracis Germination on In Vitro and In Vivo Infections. Infect. Immun.
75: 5726-5734
[Abstract]
[Full Text]
-
Bergman, N. H., Anderson, E. C., Swenson, E. E., Janes, B. K., Fisher, N., Niemeyer, M. M., Miyoshi, A. D., Hanna, P. C.
(2007). Transcriptional Profiling of Bacillus anthracis during Infection of Host Macrophages. Infect. Immun.
75: 3434-3444
[Abstract]
[Full Text]
-
Loving, C. L., Kennett, M., Lee, G. M., Grippe, V. K., Merkel, T. J.
(2007). Murine Aerosol Challenge Model of Anthrax. Infect. Immun.
75: 2689-2698
[Abstract]
[Full Text]
-
Drysdale, M., Olson, G., Koehler, T. M., Lipscomb, M. F., Lyons, C. R.
(2007). Murine Innate Immune Response to Virulent Toxigenic and Nontoxigenic Bacillus anthracis Strains. Infect. Immun.
75: 1757-1764
[Abstract]
[Full Text]
-
Heine, H. S., Bassett, J., Miller, L., Hartings, J. M., Ivins, B. E., Pitt, M. L., Fritz, D., Norris, S. L., Byrne, W. R.
(2007). Determination of Antibiotic Efficacy against Bacillus anthracis in a Mouse Aerosol Challenge Model. Antimicrob. Agents Chemother.
51: 1373-1379
[Abstract]
[Full Text]
-
Giorno, R., Bozue, J., Cote, C., Wenzel, T., Moody, K.-S., Mallozzi, M., Ryan, M., Wang, R., Zielke, R., Maddock, J. R., Friedlander, A., Welkos, S., Driks, A.
(2007). Morphogenesis of the Bacillus anthracis Spore. J. Bacteriol.
189: 691-705
[Abstract]
[Full Text]
-
Kozel, T. R., Thorkildson, P., Brandt, S., Welch, W. H., Lovchik, J. A., AuCoin, D. P., Vilai, J., Lyons, C. R.
(2007). Protective and Immunochemical Activities of Monoclonal Antibodies Reactive with the Bacillus anthracis Polypeptide Capsule. Infect. Immun.
75: 152-163
[Abstract]
[Full Text]
-
Bozue, J., Cote, C. K., Moody, K. L., Welkos, S. L.
(2007). Fully Virulent Bacillus anthracis Does Not Require the Immunodominant Protein BclA for Pathogenesis. Infect. Immun.
75: 508-511
[Abstract]
[Full Text]
-
Heninger, S., Drysdale, M., Lovchik, J., Hutt, J., Lipscomb, M. F., Koehler, T. M., Lyons, C. R.
(2006). Toxin-Deficient Mutants of Bacillus anthracis Are Lethal in a Murine Model for Pulmonary Anthrax. Infect. Immun.
74: 6067-6074
[Abstract]
[Full Text]
-
Ribot, W. J., Panchal, R. G., Brittingham, K. C., Ruthel, G., Kenny, T. A., Lane, D., Curry, B., Hoover, T. A., Friedlander, A. M., Bavari, S.
(2006). Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival. Infect. Immun.
74: 5029-5034
[Abstract]
[Full Text]
-
Stearns-Kurosawa, D. J., Lupu, F., Taylor, F. B. Jr., Kinasewitz, G., Kurosawa, S.
(2006). Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model. Am. J. Pathol.
169: 433-444
[Abstract]
[Full Text]
-
Heffernan, B. J., Thomason, B., Herring-Palmer, A., Shaughnessy, L., McDonald, R., Fisher, N., Huffnagle, G. B., Hanna, P.
(2006). Bacillus anthracis Phospholipases C Facilitate Macrophage-Associated Growth and Contribute to Virulence in a Murine Model of Inhalation Anthrax. Infect. Immun.
74: 3756-3764
[Abstract]
[Full Text]
-
Peterson, J. W., Comer, J. E., Noffsinger, D. M., Wenglikowski, A., Walberg, K. G., Chatuev, B. M., Chopra, A. K., Stanberry, L. R., Kang, A. S., Scholz, W. W., Sircar, J.
(2006). Human Monoclonal Anti-Protective Antigen Antibody Completely Protects Rabbits and Is Synergistic with Ciprofloxacin in Protecting Mice and Guinea Pigs against Inhalation Anthrax. Infect. Immun.
74: 1016-1024
[Abstract]
[Full Text]
-
Cote, C. K., Van Rooijen, N., Welkos, S. L.
(2006). Roles of Macrophages and Neutrophils in the Early Host Response to Bacillus anthracis Spores in a Mouse Model of Infection. Infect. Immun.
74: 469-480
[Abstract]
[Full Text]
-
Peachman, K. K., Rao, M., Alving, C. R., Burge, R., Leppla, S. H., Rao, V. B., Matyas, G. R.
(2006). Correlation between Lethal Toxin-Neutralizing Antibody Titers and Protection from Intranasal Challenge with Bacillus anthracis Ames Strain Spores in Mice after Transcutaneous Immunization with Recombinant Anthrax Protective Antigen. Infect. Immun.
74: 794-797
[Abstract]
[Full Text]
-
Firoved, A. M., Miller, G. F., Moayeri, M., Kakkar, R., Shen, Y., Wiggins, J. F., McNally, E. M., Tang, W.-J., Leppla, S. H.
(2005). Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice. Am. J. Pathol.
167: 1309-1320
[Abstract]
[Full Text]
-
Wu, T. H., Hutt, J. A., Garrison, K. A., Berliba, L. S., Zhou, Y., Lyons, C. R.
(2005). Intranasal Vaccination Induces Protective Immunity against Intranasal Infection with Virulent Francisella tularensis Biovar A. Infect. Immun.
73: 2644-2654
[Abstract]
[Full Text]
-
Kim, C., Gajendran, N., Mittrucker, H.-W., Weiwad, M., Song, Y.-H., Hurwitz, R., Wilmanns, M., Fischer, G., Kaufmann, S. H. E.
(2005). Human {alpha}-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA
102: 4830-4835
[Abstract]
[Full Text]